Ming Jian, He Yunzhen, Yang Yi, Hu Min, Zhao Xinran, Liu Jun, Xie Yang, Wei Yan, Chen Yingyao
Real World Solutions, IQVIA, Shanghai, 200124, China.
National Health Commission Key Laboratory of Health Technology Assessment, School of Public Health, Fudan University, Shanghai, 200032, China.
Cost Eff Resour Alloc. 2022 Oct 5;20(1):54. doi: 10.1186/s12962-022-00389-6.
Health Technology Assessment (HTA) has been widely recognized as informing healthcare decision-making, and interest in HTA of medical devices has been steadily increasing. How does the assessment of medical devices differ from that of drug therapies, and what innovations can be adopted to overcome the inherent challenges in medical device HTA?
HTA Accelerator Database was used to describe the landscape of HTA reports for medical devices from HTA bodies, and a literature search was conducted to understand the growth trend of relevant HTA publications in four case studies. Another literature review was conducted for a narrative synthesis of the characteristic differences and challenges of HTA in medical devices. We further conducted a focused Internet search of guidelines and a narrative review of methodologies specific to the HTA of medical devices.
The evidence of HTA reports and journal publications on medical devices around the world has been growing. The challenges in assessing medical devices include scarcity of well-designed randomized controlled trials, inconsistent real-world evidence data sources and methods, device-user interaction, short product lifecycles, inexplicit target population, and a lack of direct medical outcomes. Practical solutions in terms of methodological advancement of HTA for medical devices were also discussed in some HTA guidelines and literature.
To better conduct HTA on medical devices, we recommend considering multi-source evidence such as real-world evidence; standardizing HTA processes, methodologies, and criteria; and integrating HTA into decision-making.
卫生技术评估(HTA)已被广泛认为可为医疗保健决策提供信息,并且对医疗器械HTA的关注度一直在稳步上升。医疗器械评估与药物治疗评估有何不同,以及可以采用哪些创新方法来克服医疗器械HTA中固有的挑战?
使用HTA加速器数据库来描述来自HTA机构的医疗器械HTA报告的情况,并进行文献检索以了解四个案例研究中相关HTA出版物的增长趋势。还进行了另一项文献综述,以对医疗器械HTA的特征差异和挑战进行叙述性综合。我们进一步针对医疗器械HTA的指南进行了重点互联网搜索,并对其方法进行了叙述性综述。
世界各地关于医疗器械的HTA报告和期刊出版物的证据一直在增加。评估医疗器械的挑战包括精心设计的随机对照试验稀缺、真实世界证据数据来源和方法不一致、器械与用户的相互作用、产品生命周期短、目标人群不明确以及缺乏直接的医疗结果。一些HTA指南和文献中也讨论了医疗器械HTA方法改进方面的实际解决方案。
为了更好地对医疗器械进行HTA,我们建议考虑多源证据,如真实世界证据;规范HTA流程、方法和标准;并将HTA纳入决策过程。